AVITA Medical (AVHHL) Gains from Investment Securities (2023 - 2025)

AVITA Medical (AVHHL) has reported Gains from Investment Securities for 3 consecutive years, with -$617000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Gains from Investment Securities fell 191.68% year-over-year to -$617000.0; the trailing twelve-month figure through Dec 2025 stood at -$2.2 million (down 898.91% YoY), and the FY2025 full-year result was -$2.2 million, down 898.91% from the prior year.
• Gains from Investment Securities declined to -$617000.0 in Q4 2025 per AVHHL's latest filing, from -$40000.0 in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $870000.0 in Q1 2024 and bottomed at -$2.1 million in Q2 2024.
• Historically, Gains from Investment Securities has averaged -$133222.2 across 3 years, with a median of -$40000.0 in 2025.
• The widest YoY moves for Gains from Investment Securities: up 43.98% in 2025, down 191.68% in 2025.
• Over 3 years, Gains from Investment Securities stood at $716000.0 in 2023, then fell by 6.01% to $673000.0 in 2024, then sank by 191.68% to -$617000.0 in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$617000.0, -$40000.0, and -$1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.